-
Plant Exosome-like Nanovesicles Restore Sertoli Cell Functio
2026-08-06
The referenced study demonstrates that exosome-like nanovesicles derived from Cistanche deserticola (CDELNs) alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The findings uncover a miRNA-mediated mechanism and suggest promising cross-kingdom therapeutic strategies for male reproductive protection.
-
Resazurin Cell Viability Assay Kit: Sensitivity, Mechanism,
2026-08-06
Explore the Resazurin Cell Viability Assay Kit’s unique mechanism and unmatched sensitivity for cell viability analysis. This article dives into recent scientific findings and offers a translational perspective on advanced assay choice and application.
-
Applied EGCG: Protocols for Apoptosis, Inflammation & IVDD M
2026-08-05
(-)-Epigallocatechin gallate (EGCG) stands out as a versatile tool for apoptosis assays, antiangiogenic research, and advanced drug delivery in inflammatory and degenerative models. This guide translates recent breakthroughs—like multifunctional hydrogel microspheres for intervertebral disc degeneration—into actionable workflows, troubleshooting tips, and cross-domain insights for biomedical scientists.
-
Astrocyte-Driven Microglia Polarization via p38 MAPK in Neur
2026-08-05
This study demonstrates that 2-chloroethanol activates A1 astrocytes through ROS-induced p38 MAPK/NF-κB and AP-1 signaling, leading to microglial M1 polarization and neuroinflammation. The findings clarify the sequence and mechanisms of glial cell interplay following toxic brain injury, outlining new avenues for targeted intervention in neuroinflammatory conditions.
-
Dabigatran Etexilate: Translating Thrombin Inhibition to Inn
2026-08-04
This thought-leadership article explores the mechanistic, translational, and strategic dimensions of dabigatran etexilate—an oral direct thrombin inhibitor. Integrating evidence from pivotal clinical studies and recent workflow advances, the piece guides translational researchers on leveraging dabigatran etexilate for innovative anticoagulant research, with insight on protocol parameters, competitive landscape, and future directions.
-
Ribotoxic Stress Response Governs UV-Induced Cell Death via
2026-08-04
A recent study by Sinha et al. reveals that UV-triggered cell death is mediated by the ribotoxic stress response via the kinase ZAK, challenging the traditional emphasis on the DNA damage response. These findings redefine our understanding of programmed cell death pathways and offer new avenues for dissecting kinase signaling in stress biology.
-
S Tag Peptide (A6007): Workflow Parameters and Best Practice
2026-08-03
S Tag Peptide (SKU A6007) addresses key challenges in recombinant protein solubility, detection, and affinity purification, especially when conventional tags result in aggregation or low yields. It is not suitable for workflows requiring ethanol solubility or standalone ribonuclease activity. Use this tag where sensitive antibody-based detection or solubility enhancement are needed in molecular biology workflows.
-
DHHC9-STRN4 Palmitoylation Inhibition Suppresses YAP Metasta
2026-08-03
This study reveals that DHHC9-mediated palmitoylation of STRN4 drives YAP-dependent cancer metastasis, introducing a new axis for targeted intervention in adenocarcinoma. Pharmacological inhibition of DHHC9 effectively blocks tumor cell migration, highlighting an emerging therapeutic strategy and the importance of post-translational modifications in oncogenic signaling.
-
Lovastatin as an HMG-CoA Reductase Inhibitor: Experimental W
2026-08-02
Lovastatin from APExBIO empowers researchers with robust, reproducible inhibition of cholesterol biosynthesis and downstream cellular effects. This article details stepwise protocols, assay optimization, and troubleshooting tips, enabling precise modulation of cell proliferation and apoptosis in diverse biomedical models.
-
Sulforaphane: Applied Workflows for Chemoprevention & Inflam
2026-08-01
Sulforaphane (1-isothiocyanato-4-(methylsulfinyl)-butane) empowers researchers to model cancer chemoprevention and inflammation with precision, leveraging robust, peer-reviewed protocols. This guide translates the latest mechanistic insights into executable experimental workflows, troubleshooting tips, and advanced applications—bridging oxidative stress, cell cycle arrest, and inflammasome research.
-
N6-Methyl-dATP: Unlocking Epigenetic Precision in AML Resear
2026-07-31
Explore how N6-Methyl-dATP advances methylation modification research and DNA replication fidelity studies, with a unique focus on acute myeloid leukemia (AML) epigenetics. Gain actionable insights for assay optimization and translational applications.
-
BV6, IAP Antagonists, and Next-Gen Apoptosis Modulation
2026-07-31
This thought-leadership article explores the strategic use of BV6—a potent IAP antagonist from APExBIO—in advancing translational research on programmed cell death. By connecting mechanistic insight with practical guidance, it redefines the landscape of apoptosis modulation, radiosensitization, and disease modeling in oncology and beyond. The piece critically contrasts BV6’s mechanism with emerging findings on mitochondrial apoptosis, referencing recent studies to highlight both opportunities and caveats for translational researchers.
-
Metal-Ion-Chelating l-Phe Nanostructures Boost ICB in Tumors
2026-07-30
This study reveals that metal-ion-chelating l-phenylalanine nanostructures, when combined with short-term starvation, remodel the tumor microenvironment and enhance dendritic cell activation, leading to improved immune checkpoint blockade (ICB) efficacy in breast cancer. The findings introduce a novel, electrophysiology-driven approach to overcoming immune resistance in solid tumors.
-
DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te
2026-07-30
DiI (DiIC18(3)) is a lipophilic orange fluorescent probe designed for selective plasma membrane labeling in live and fixed biological samples. It enables high-contrast visualization for applications such as neuronal tracing and cell migration assays, but is unsuitable for aqueous-only protocols or targeting intracellular organelles. Careful adherence to solvent and storage guidelines is essential for reliable results.
-
KU-55933: Potent ATM Kinase Inhibitor for DNA Damage Researc
2026-07-29
KU-55933 is a highly selective ATM kinase inhibitor with nanomolar potency, widely used in DNA damage response and cancer research. It suppresses ATM-mediated phosphorylation events, induces G1 cell cycle arrest, and inhibits cancer cell proliferation under defined conditions.
454 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page